Ipsen announces acquisition of research partner Syntaxin

18-07-2013

Ipsen announces acquisition of research partner Syntaxin

On July 15, French pharmaceutical company Ipsen announced it has closed the acquisition of life sciences company and research partner Syntaxin.


Ipsen, Syntaxin, merger, acquisition, Harvard Medical School

LSIPR